In the summer of 2004, Rafaat founded Lifescience Dynamics. He had a vision of what would make an effective global decision support service, dedicated exclusively to pharmaceutical and biotechnology industries. It would have to be the best in class market research, competitive intelligence and market access, combined with first-rate people and a business model that met their clients’ global insight and foresight requirements. He wanted to deliver a unique service model that hadn’t been available to the market previously, giving pharmaceutical companies a new and interesting way to manage their market, competitors and payer requirements.

Prior to founding Lifescience Dynamics, Rafaat was Vice President of a London-based consulting practice where he was responsible for numerous international projects for top 10 pharmaceutical companies, focusing on all aspects of the clinical development and commercialisation environments at US, European and global levels. He has advanced knowledge of competitive intelligence, qualitative and quantitative market research techniques, market access, pricing and reimbursements, and he gets personally involved in all aspects of the client engagement process as well as execution of studies. He has also previously worked for Eli Lilly & Company, Pepsi-Cola and McDonald's in a management training programme.

Rafaat has a truly international background. He was born in India, brought up in Oman/UAE, gained a business degree in the USA and an MBA from Manchester Business School in the UK. As well as the UK, he has worked in the USA, India, Abu Dhabi and Dubai. He belongs to a large, traditional close-knit Indian family with strong family ethics and values of honesty and hard work. He says: "I was told from childhood and have always believed that it's not just what you do but how you do it that's important."

Petra Leiding is Director of Market Intelligence & Strategic Projects at HELM AG, where she has worked for over seven years. She specializes in uncovering market insights to drive new business opportunities at HELM Pharma. Petra promotes 2 and 3D printing opportunities including project lead of technical development, market access and financials. Previously, Petra held team leader roles in business insights and analytics at Teva Pharmaceuticals and AstraZeneca, bringing overall more than 25 years of professional experience in market research, pricing, and strategies mostly within the pharmaceutical industry.

The Pop in Your Job
I love transforming complex data into intelligent, automated solutions that truly make an impact. Seeing how AI and automation streamline workflows, empower teams and at the same time gives freedom for strategic projects as well as in depths analyses motivates me every day!

Mirko Lotz is the Global Market Intelligence Manager at Bachem, where he has been contributing since 2016 in various Science Marketing roles before transitioning into his current global Market and Competitive Intelligence (MI/CI) position. Prior to joining Bachem, he spent nearly eight years as a Business Development Engineer and Consultant. Mirko holds a PhD in Biochemistry from the University of Frankfurt.

Leandro Gaspar is the I&A Director, Global CI & Analytics at Reckitt, where he has led the global competitive insights team for nearly four years. In this role, he provides strategic analytics and market intelligence to support business growth and innovation across Reckitt’s consumer healthcare portfolio. With a career spanning over three decades in the pharmaceutical and consumer healthcare industries, Leandro brings deep expertise in competitive assessment, strategic planning, and market research. Prior to joining Reckitt, Leandro spent more than 14 years at Sanofi as Market Intelligence Lead, Consumer Market Insights, where he was instrumental in delivering actionable insights and guiding strategic decisions across various therapeutic areas. Before that, he was working in various business intelligence positions at Bristol-Myers Squibb for over 11 years, where he supported commercial strategies through robust analytics and forecasting.

The Pop in Your Job
I am passionate about leveraging data to drive informed decision-making and create value for customers and stakeholders.

Michele Spinetta is the Corporate Market Research Lead at MENARINI Group, where he has spent over 20 years driving market insights and strategy. Before joining MENARINI, he worked in Market Research and as a Business Analyst at Novo Nordisk A/S, and held roles outside the pharmaceutical industry at companies such as ABN Amro and Microsoft.

Lifescience Dynamics works across five practice areas: Market Research, Competitive Intelligence, and Market Access, Strategic Advisory and Real-World Evidence. The company’s success is attributed to its multinational team who work in a collaborative and nurturing environment, where they can develop their skills and advance their careers. Founded in 2004, Lifescience Dynamics has its headquarters in London and an office in Toronto, as well as virtual offices in Boston, New York, San Francisco and Vancouver.

HELM Pharma is a subsidiary of HELM AG a Hamburg-based family company established in 1900. With over 1,621 employees, HELM AG is one of the world’s largest independent chemicals marketing companies. The Company secures access to the world’s key markets through its specific regional knowledge and over 100 branches, sales offices and participations in over 30 countries. HELM Pharma as a digital company develops plain as well as highly specialized and added-value generics to be marketed by partners mainly in Europe, USA and MENA.

The Swiss-based Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides. With over 50 years of experience and expertise Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services. Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia.

We protect, heal and nurture in the relentless pursuit of a cleaner, healthier world. Our products reach millions of people every day, as we fight to improve global access to the highest quality hygiene, wellness and nourishment. We’re a growing community of 40,000+ diverse, talented entrepreneurs, and the driving force behind some of the world’s most loved and trusted brands. Our portfolio includes household names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Lysol, Dettol, Harpic, Cillit Bang, Finish and Vanish. Hygiene, Health and Nutrition are the focus areas of our business, and the categories under which our brands are organised. Each area is dedicated to building sustainable solutions that will help us address the challenges presented by global mega-trends like urbanisation, climate change and digital transformation. These global pressures are challenging public health systems and increasing the need for improved hygiene products, services and education. We continuously innovate in areas like personalised nutrition, wellness, and digital health and hygiene so that individuals, families and communities can live cleaner, healthier lives.

The Menarini Group is a leading international pharmaceutical and diagnostics company, present in 140 countries worldwide, with a turnover of 4,37 Billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, infectious diseases, diabetes, and anti-inflammatory/analgesics. The Group’s pharmaceutical production is carried out in its 18 manufacturing plants, which produce over 609 million packets of product a year and distribute them to five continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients all over the world.